Ameriprise’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.2M Sell
59,721
-6,509
-10% -$1.87M ﹤0.01% 1443
2025
Q1
$20.4M Sell
66,230
-658
-1% -$203K 0.01% 1299
2024
Q4
$23.6M Buy
66,888
+19
+0% +$6.7K 0.01% 1227
2024
Q3
$24M Sell
66,869
-6,428
-9% -$2.3M 0.01% 1221
2024
Q2
$23.4M Buy
73,297
+2,301
+3% +$734K 0.01% 1182
2024
Q1
$16.3M Sell
70,996
-2,037
-3% -$468K ﹤0.01% 1434
2023
Q4
$16.1M Sell
73,033
-6,406
-8% -$1.41M ﹤0.01% 1409
2023
Q3
$17.9M Sell
79,439
-978
-1% -$221K 0.01% 1296
2023
Q2
$17.8M Sell
80,417
-6,453
-7% -$1.42M 0.01% 1344
2023
Q1
$19.5M Buy
86,870
+7,359
+9% +$1.65M 0.01% 1280
2022
Q4
$22.1M Sell
79,511
-2,786
-3% -$775K 0.01% 1178
2022
Q3
$17.2M Buy
82,297
+1,540
+2% +$322K 0.01% 1275
2022
Q2
$19M Sell
80,757
-1,757
-2% -$414K 0.01% 1237
2022
Q1
$14.8M Sell
82,514
-1,034
-1% -$186K ﹤0.01% 1587
2021
Q4
$18.1M Buy
83,548
+2,151
+3% +$465K 0.01% 1501
2021
Q3
$15M Sell
81,397
-2,418
-3% -$446K ﹤0.01% 1501
2021
Q2
$15M Sell
83,815
-72,266
-46% -$13M ﹤0.01% 1572
2021
Q1
$26.1M Sell
156,081
-23,828
-13% -$3.99M 0.01% 1124
2020
Q4
$27.3M Sell
179,909
-21,544
-11% -$3.27M 0.01% 1044
2020
Q3
$20.3M Buy
201,453
+6,334
+3% +$640K 0.01% 1062
2020
Q2
$23.6M Buy
195,119
+15,424
+9% +$1.87M 0.01% 969
2020
Q1
$17M Buy
179,695
+56,200
+46% +$5.33M 0.01% 1035
2019
Q4
$10.9M Sell
123,495
-7,326
-6% -$645K ﹤0.01% 1680
2019
Q3
$10.4M Buy
130,821
+15,668
+14% +$1.25M ﹤0.01% 1658
2019
Q2
$8.99M Sell
115,153
-6,975
-6% -$544K ﹤0.01% 1817
2019
Q1
$14.3M Sell
122,128
-3,261
-3% -$383K 0.01% 1388
2018
Q4
$13.7M Sell
125,389
-8,673
-6% -$944K 0.01% 1339
2018
Q3
$17.1M Buy
134,062
+1,581
+1% +$202K 0.01% 1423
2018
Q2
$15M Buy
132,481
+3,303
+3% +$374K 0.01% 1397
2018
Q1
$14.5M Sell
129,178
-40,195
-24% -$4.52M 0.01% 1356
2017
Q4
$25.1M Buy
169,373
+2,263
+1% +$335K 0.01% 938
2017
Q3
$19.6M Sell
167,110
-5,936
-3% -$696K 0.01% 1051
2017
Q2
$22.4M Buy
173,046
+27,304
+19% +$3.54M 0.01% 951
2017
Q1
$19.7M Sell
145,742
-9,220
-6% -$1.25M 0.01% 1024
2016
Q4
$22.2M Buy
154,962
+37,341
+32% +$5.36M 0.01% 932
2016
Q3
$13.9M Buy
117,621
+2,265
+2% +$267K 0.01% 1188
2016
Q2
$12.2M Buy
115,356
+1,995
+2% +$211K 0.01% 1248
2016
Q1
$12.6M Sell
113,361
-2,642
-2% -$294K 0.01% 1242
2015
Q4
$18.2M Sell
116,003
-667
-0.6% -$104K 0.01% 976
2015
Q3
$15.3M Sell
116,670
-3,175
-3% -$417K 0.01% 1121
2015
Q2
$20.9M Sell
119,845
-74,487
-38% -$13M 0.01% 981
2015
Q1
$33.5M Buy
194,332
+18,001
+10% +$3.1M 0.02% 705
2014
Q4
$22.8M Buy
176,331
+58,808
+50% +$7.61M 0.01% 886
2014
Q3
$15.1M Buy
117,523
+8,615
+8% +$1.11M 0.01% 1140
2014
Q2
$9.64M Sell
108,908
-4,959
-4% -$439K 0.01% 1570
2014
Q1
$10.7M Sell
113,867
-136,524
-55% -$12.8M 0.01% 1450
2013
Q4
$28.3M Sell
250,391
-12,332
-5% -$1.39M 0.02% 793
2013
Q3
$20.7M Buy
262,723
+163,336
+164% +$12.9M 0.01% 971
2013
Q2
$6.54M Buy
+99,387
New +$6.54M ﹤0.01% 1719